血管紧张素
血管紧张素 性质
| 储存条件 | -20°C |
|---|---|
| 形态 | 粉末 |
| 密度 | 1.45±0.1 g/cm3(Predicted) |
| 酸度系数(pKa) | 3.56±0.10(Predicted) |
| 颜色 | 白色至米白色 |
| 水溶解性 | Water : ≥ 257.5 mg/mL (249.48 mM) |
| 序列 | H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-OH |
| InChIKey | JVCJXRGXGITABA-IAQGTVMASA-N |
| CAS 数据库 | 58-49-1 |
血管紧张素 用途与合成方法
Angiotensin receptor.
By day 12, systolic blood pressure (SBP) increases significantly in Angiotensin II 5-valine infused rats (197±7 mm Hg). As shown, the development of hypertension in ANG II infused rats is prevented by losartan treatment. Blood and kidney samples are harvested, subjected to HPLC to separate Angiotensin II 5-valine (exogenous) from Ile5-ANG II (endogenous) and the fractions are measured by radioimmunoassay. In the Angiotensin II 5-valine infused rats treated with losartan, total plasma ANG II levels are elevated to a greater extent than in rats not treated with losartan (289±20 v 119±14 fmol/mL). However, losartan markedly decrease by 88% the enhancement of intrarenal Val5-ANG II content that occurred in the rats infused with Val5-ANG II alone.
纯度(HPLC) ≥98.0%
醋酸根含量5.0%～12.0%
水分含量≤8.0%
肽含量≥80.0%
血管紧张素 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-11-08 | HY-P0108 | 血管紧张素 | 58-49-1 | 5mg | 450 |
| 2024-11-08 | HY-P0108 | 血管紧张素 | 58-49-1 | 10mg | 550 |
